Mixed dementia - the most common cause of dementia

被引:123
作者
Korczyn, AD [1 ]
机构
[1] Tel Aviv Univ, Sch Med, Sieratzki Chair Neurol, IL-69978 Ramat Aviv, Israel
来源
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY | 2002年 / 977卷
关键词
Alzheimer's disease; vascular dementia; diagnosis; pathogenesis; autoimmune mechanisms; mixed dementia;
D O I
10.1111/j.1749-6632.2002.tb04807.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The existence of vascular dementia (VaD) was first identified by Marie, who described the etat lacunaire, and by Binswanger, who identified white matter lesions. The role of cortical lesions, while clear to clinicians, was highlighted only later by the pathological studies of Tomlinson and the clinical demonstrations of Hachinski et al., who have defined multi-infarct dementia. Lately, the emphasis shifted to pathogenic mechanisms with the identification of a multitude of processes, including lipohyalinosis, cardiac dysfunction, and genetic causes, to name only a few. Epidemiologic studies have demonstrated the high frequency of VaD, as well as the fact that vascular factors can contribute to Alzheimer's disease (AD). All these considerations converge to the realization that VaD is an extremely important clinical entity and that its prevention and treatment are within reach. In fact, there are more data on how to prevent strokes (and presumably VaD) than AD. Moreover, many factors that were identified as contributing to cerebrovascular disease in general and VaD in particular are frequently suspected as predisposing to AD as well. This surprising finding highlights the importance of mixed vascular-degenerative dementia as a disorder that has to be properly defined and has important implications on prevention and treatment.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 19 条
[1]   A WHITE MATTER DISORDER IN DEMENTIA OF THE ALZHEIMER TYPE - A PATHOANATOMICAL STUDY [J].
BRUN, A ;
ENGLUND, E .
ANNALS OF NEUROLOGY, 1986, 19 (03) :253-262
[2]   CRITERIA FOR THE DIAGNOSIS OF ISCHEMIC VASCULAR DEMENTIA PROPOSED BY THE STATE OF CALIFORNIA ALZHEIMERS-DISEASE-DIAGNOSTIC-AND-TREATMENT-CENTERS [J].
CHUI, HC ;
VICTOROFF, JI ;
MARGOLIN, D ;
JAGUST, W ;
SHANKLE, R ;
KATZMAN, R .
NEUROLOGY, 1992, 42 (03) :473-480
[3]   Alzheimer disease as a vascular disorder - Nosological evidence [J].
de la Torre, JC .
STROKE, 2002, 33 (04) :1152-1162
[4]   Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease [J].
Esiri, MM ;
Nagy, Z ;
Smith, MZ ;
Barnetson, L ;
Smith, AD .
LANCET, 1999, 354 (9182) :919-920
[5]   LEUKOARAIOSIS [J].
HACHINSKI, VC ;
POTTER, P ;
MERSKEY, H .
ARCHIVES OF NEUROLOGY, 1987, 44 (01) :21-23
[6]  
KORCZYN AD, 1999, VASCULAR DEMENTIA
[7]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[8]  
Mega Michael S., 2000, Int J Neuropsychopharmacol, V3, P3, DOI 10.1017/S1461145700001942
[9]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[10]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159